Resolian Drug discovery > Basic Research Products & Reviews

Focused strategic science team, and one of the largest purpose-built bioanalytical facilities in Europe.

Biomarker strategy is critical to success. Our personalized biomarker solutions help drive your development to market.  The expert biomarker teams support non-clinical and clinical biomarker method development, validation, and sample analysis. 

Resolian has established itself as a world-class leader in biopharmaceutical drug development through analytical excellence with over 500 scientists across three global labs.

Our industry leading  bioanalytical solutions have helped our clients develop  new peptide therapeutics  to improve the quality of life. Combining our experience and cutting-edge technology, we have has developed and validated methods using LC-MS/MS to quantify levels of peptides in plasma at levels as low as 10 pg/mL.

Our flow cytometry service offers a range of assays to support pre-clinical through to late phase drug development.

Our LC-MS capabilities offer a flexible service from discovery, through to regulated GLP preclinical and GCP clinical studies.